Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$16 Mln
Revenue (TTM)
$134 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.2
Industry P/E
24.51
EV/EBITDA
75
Div. Yield
0 %
Debt to Equity
0.1
Book Value
$--
EPS
$-2
Face value
--
Shares outstanding
6,176,778
CFO
$83.23 Mln
EBITDA
$108.32 Mln
Net Profit
$56.07 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Natural Alternatives International (NAII)
| -25.1 | -1.1 | -25.1 | -23.9 | -33.8 | -30.2 | -15.0 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Natural Alternatives International (NAII)
| -16.9 | -33.8 | -22.2 | -33.7 | 19.5 | 32.7 | -18.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Natural Alternatives International (NAII)
|
2.7 | 16.2 | 134.5 | -12.3 | -3.7 | -18.1 | -- | 0.2 |
| 12.5 | 3,981.1 | 3,018.8 | 72.1 | 12.6 | -80 | 56.7 | 86.1 | |
| 168.5 | 8,210.1 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 92.9 | |
| 73.2 | 13,446.3 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 42.5 | 4,055.0 | 761.4 | 99.7 | 7.3 | 15 | 46.5 | 5.7 | |
| 13.3 | 11,120.8 | 345,831.0 | 56,586.0 | 21.5 | 15.8 | 18.2 | 2.8 | |
| 23.1 | 11,474.6 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.8 | |
| 8.2 | 7,645.3 | 7,227.1 | 386.1 | 16.6 | 6.9 | 13.8 | 0.9 | |
| 199.6 | 3,841.5 | 268.1 | 124.5 | 60.0 | 13.5 | 31.5 | 4.0 | |
| 37.7 | 3,099.9 | 158.3 | -68.9 | -29.3 | -113 | -- | 69.3 |
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and... Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California. Address: 1535 Faraday Avenue, Carlsbad, CA, United States, 92008 Read more
Chairman of the Board & CEO
Mr. Mark A. LeDoux J.D.
Chairman of the Board & CEO
Mr. Mark A. LeDoux J.D.
Headquarters
Carlsbad, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Natural Alternatives International (NAII) is $2.68 (NASDAQ) as of 02-Apr-2026 16:00 EDT. Natural Alternatives International (NAII) has given a return of -33.76% in the last 3 years.
Since, TTM earnings of Natural Alternatives International (NAII) is negative, P/E ratio is not available.
The P/B ratio of Natural Alternatives International (NAII) is 0.23 times as on 31-Mar-2026, a 96 discount to its peers’ median range of 5.66 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.49
|
0.30
|
|
2024
|
-4.93
|
0.43
|
|
2023
|
16.72
|
0.47
|
|
2022
|
6.00
|
0.73
|
|
2021
|
9.87
|
1.33
|
The 52-week high and low of Natural Alternatives International (NAII) are Rs 4.96 and Rs 2.33 as of 05-Apr-2026.
Natural Alternatives International (NAII) has a market capitalisation of $ 16 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Natural Alternatives International (NAII), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.